SCHEMBL10104334

SCHEMBL10104334

Cc1cc(N2CCC(N(C)C)CC2)c(F)c(C(F)(F)F)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 5/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
HSD11B1 P28845 1/20 0.36
NOTUM Q6P988 2/20 0.35
SETD2 Q9BYW2 1/20 0.34
TIPARP Q7Z3E1 1/20 0.34
CSF1R P07333 1/20 0.33
CDK4 P11802 1/20 0.33
CDK6 Q00534 1/20 0.33
PDCD1 Q15116 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
WDR5 P61964 2/20 0.33
KCNH2 Q12809 2/20 0.32
CYP2D6 P10635 1/20 0.32
HRH1 P35367 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10104397 0.92 NOTUM (0.39) SOS1HTR2AHTR2CHTR2BHSD11B1
SCHEMBL10104379 0.87 SOS1 (0.37) SOS1HTR2AHTR2CHTR2BHSD11B1
SCHEMBL10104392 0.82 HTR2A (0.38) HTR2AHTR2CHTR2BNOTUM
SCHEMBL20374410 0.81 HSD11B1 (0.43) SOS1HSD11B1NOTUMTIPARPCSF1R
SCHEMBL10104401 0.80 HTR2A (0.37) HTR2AHTR2CHTR2BNOTUM
SCHEMBL20374348 0.80 SOS1 (0.37) SOS1HTR2AHTR2CHTR2BHSD11B1
SCHEMBL10104391 0.80 ALDH1A1 (0.39) HTR2AHTR2CHTR2B
SCHEMBL10104326 0.79 ADRB2 (0.44) HTR2AHTR2CHTR2BCDK4WDR5
SCHEMBL10104492 0.79 SOS1 (0.39) SOS1HSD11B1NOTUMWDR5
SCHEMBL10104493 0.79 SOS1 (0.39) SOS1HSD11B1NOTUMWDR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889665-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-18 US disclosed
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-8653087-B2 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-18 US disclosed
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
US-20110183952-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183952-A1 NEW CHEMICAL COMPOUNDS MKI67, CCNA1, CCNT1 SOS1 985/4885HTR2A 3601/4885HTR2C 2640/4885
US-20110312939-A1 NEW CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 SOS1 943/4885HTR2A 4089/4885HTR2C 2673/4885
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS CCNT1, CCNA1, CCND1 SOS1 1760/4885HTR2A 2935/4885HTR2C 2276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.